tiprankstipranks
Metlife (MX:MET)
:MET
Mexico Market

Metlife (MET) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MET Analyst Ratings

Strong Buy
12Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Metlife
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$1,792.89
▲(7.86% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $1,792.89 with a high forecast of $2,011.05 and a low forecast of $1,520.96. The average price target represents a 7.86% change from the last price of $1,662.26.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1222":"$1,222","1617":"$1,617","2012":"$2,012","1419.5":"$1,419.5","1814.5":"$1,814.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2011.05233812,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.01K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1792.8938721054544,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.79K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1520.9639532,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.52K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1222,1419.5,1617,1814.5,2012],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1662.26,1689.0901798553846,1715.9203597107692,1742.7505395661537,1769.5807194215386,1796.4108992769231,1823.2410791323077,1850.0712589876923,1876.901438843077,1903.7316186984615,1930.561798553846,1957.391978409231,1984.2221582646155,{"y":2011.05233812,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1662.26,1672.3087593927273,1682.3575187854544,1692.4062781781818,1702.455037570909,1712.5037969636362,1722.5525563563635,1732.6013157490909,1742.6500751418182,1752.6988345345453,1762.7475939272726,1772.79635332,1782.845112712727,{"y":1792.8938721054544,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1662.26,1651.3910733230769,1640.522146646154,1629.6532199692308,1618.7842932923077,1607.9153666153848,1597.0464399384616,1586.1775132615385,1575.3085865846153,1564.4396599076924,1553.5707332307693,1542.7018065538462,1531.8328798769232,{"y":1520.9639532,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1475.548,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1465.37,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1412.156,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1365.657,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1395.387,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1302.516,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1271.278,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1223.246,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1315.66,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1433.127,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1491.008,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1652.031,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1662.26,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2,011Average Price Target$1,793Lowest Price Target$1,521
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:MET
Morgan Stanley
Morgan Stanley
$1,740.66$1,875.86
Buy
12.85%
Upside
Assigned
08/24/26
Morgan Stanley Releases a Buy Rating on Metlife (MET)
Wells Fargo
$1,706.86$1,842.06
Buy
10.82%
Upside
Reiterated
08/19/26
Metlife (MET) Gets a Buy from Wells Fargo
Mizuho Securities Analyst forecast on MX:MET
Mizuho Securities
Mizuho Securities
$1,723.76$1,892.76
Buy
13.87%
Upside
Reiterated
08/11/26
Mizuho Securities Reaffirms Their Buy Rating on Metlife (MET)
KBW
$1,774.46$1,825.16
Buy
9.80%
Upside
Reiterated
08/11/26
Metlife (MET) Gets a Buy from KBW
J.P. Morgan Analyst forecast on MX:MET
J.P. Morgan
J.P. Morgan
$1,791.36$1,825.16
Buy
9.80%
Upside
Reiterated
08/11/26
MetLife price target raised to $108 from $106 at JPMorganMetLife price target raised to $108 from $106 at JPMorgan
Piper Sandler Analyst forecast on MX:MET
Piper Sandler
Piper Sandler
$1,520.96
Hold
-8.50%
Downside
Reiterated
08/06/26
Metlife (MET) Receives a Hold from Piper Sandler
Barclays Analyst forecast on MX:MET
Barclays
Barclays
$1,588.56$1,639.26
Buy
-1.38%
Downside
Reiterated
08/06/26
Analysts' Top Financial Picks: Metlife (MET), Ridgepost Capital (RPC)
Bank of America Securities Analyst forecast on MX:MET
Bank of America Securities
Bank of America Securities
$1,740.66$2,011.05
Buy
20.98%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Financial Companies: Swiss Re AG (Other OTC: SSREF) and Metlife (NYSE: MET)
TD Cowen
$1,470.27$1,774.46
Buy
6.75%
Upside
Reiterated
07/22/26
MetLife price target raised to $105 from $87 at TD CowenMetLife price target raised to $105 from $87 at TD Cowen
Jefferies Analyst forecast on MX:MET
Jefferies
Jefferies
$1,740.66
Buy
4.72%
Upside
Reiterated
07/09/26
Jefferies Sticks to Its Buy Rating for Metlife (MET)
UBS
$1,723.76$1,774.46
Buy
6.75%
Upside
Assigned
07/08/26
UBS Sticks to Its Buy Rating for Metlife (MET)
Raymond James Analyst forecast on MX:MET
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Hold
Reiterated
06/30/26
Metlife (MET) Receives a Hold from Raymond James
Evercore ISI Analyst forecast on MX:MET
Evercore ISI
Evercore ISI
$1,605.46$1,622.36
Hold
-2.40%
Downside
Reiterated
04/09/26
MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI
Argus Research Analyst forecast on MX:MET
Argus Research
Argus Research
$1,520.96
Buy
-8.50%
Downside
Reiterated
12/08/25
MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus
BMO Capital Analyst forecast on MX:MET
BMO Capital
BMO Capital
$1,385.77$1,419.57
Hold
-14.60%
Downside
Reiterated
09/30/25
BMO Capital Keeps Their Hold Rating on Metlife (MET)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:MET
Morgan Stanley
Morgan Stanley
$1,740.66$1,875.86
Buy
12.85%
Upside
Assigned
08/24/26
Morgan Stanley Releases a Buy Rating on Metlife (MET)
Wells Fargo
$1,706.86$1,842.06
Buy
10.82%
Upside
Reiterated
08/19/26
Metlife (MET) Gets a Buy from Wells Fargo
Mizuho Securities Analyst forecast on MX:MET
Mizuho Securities
Mizuho Securities
$1,723.76$1,892.76
Buy
13.87%
Upside
Reiterated
08/11/26
Mizuho Securities Reaffirms Their Buy Rating on Metlife (MET)
KBW
$1,774.46$1,825.16
Buy
9.80%
Upside
Reiterated
08/11/26
Metlife (MET) Gets a Buy from KBW
J.P. Morgan Analyst forecast on MX:MET
J.P. Morgan
J.P. Morgan
$1,791.36$1,825.16
Buy
9.80%
Upside
Reiterated
08/11/26
MetLife price target raised to $108 from $106 at JPMorganMetLife price target raised to $108 from $106 at JPMorgan
Piper Sandler Analyst forecast on MX:MET
Piper Sandler
Piper Sandler
$1,520.96
Hold
-8.50%
Downside
Reiterated
08/06/26
Metlife (MET) Receives a Hold from Piper Sandler
Barclays Analyst forecast on MX:MET
Barclays
Barclays
$1,588.56$1,639.26
Buy
-1.38%
Downside
Reiterated
08/06/26
Analysts' Top Financial Picks: Metlife (MET), Ridgepost Capital (RPC)
Bank of America Securities Analyst forecast on MX:MET
Bank of America Securities
Bank of America Securities
$1,740.66$2,011.05
Buy
20.98%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Financial Companies: Swiss Re AG (Other OTC: SSREF) and Metlife (NYSE: MET)
TD Cowen
$1,470.27$1,774.46
Buy
6.75%
Upside
Reiterated
07/22/26
MetLife price target raised to $105 from $87 at TD CowenMetLife price target raised to $105 from $87 at TD Cowen
Jefferies Analyst forecast on MX:MET
Jefferies
Jefferies
$1,740.66
Buy
4.72%
Upside
Reiterated
07/09/26
Jefferies Sticks to Its Buy Rating for Metlife (MET)
UBS
$1,723.76$1,774.46
Buy
6.75%
Upside
Assigned
07/08/26
UBS Sticks to Its Buy Rating for Metlife (MET)
Raymond James Analyst forecast on MX:MET
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Hold
Reiterated
06/30/26
Metlife (MET) Receives a Hold from Raymond James
Evercore ISI Analyst forecast on MX:MET
Evercore ISI
Evercore ISI
$1,605.46$1,622.36
Hold
-2.40%
Downside
Reiterated
04/09/26
MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI
Argus Research Analyst forecast on MX:MET
Argus Research
Argus Research
$1,520.96
Buy
-8.50%
Downside
Reiterated
12/08/25
MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus
BMO Capital Analyst forecast on MX:MET
BMO Capital
BMO Capital
$1,385.77$1,419.57
Hold
-14.60%
Downside
Reiterated
09/30/25
BMO Capital Keeps Their Hold Rating on Metlife (MET)
Stocks with the Highest Top Analyst Consensus in the Financial Sector
PLMRPalomar Holdings
BLKBlackRock
RIOTRiot Platforms
CLSKCleanspark
SPGIS&P Global
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

3 Months
Success Rate
24/35 ratings generated profit
69%
Average Return
+7.18%
Copying Ryan Krueger's trades and holding each position for 3 Months would result in 68.57% of your transactions generating a profit, with an average return of +7.18% per trade.
1 Year
Success Rate
31/35 ratings generated profit
89%
Average Return
+17.97%
Copying Ryan Krueger's trades and holding each position for 1 Year would result in 88.57% of your transactions generating a profit, with an average return of +17.97% per trade.
2 Years
Bob HuangMorgan Stanley
Success Rate
22/22 ratings generated profit
100%
Average Return
+25.03%
Copying Bob Huang's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
19
15
19
19
19
Hold
5
7
5
3
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
22
24
22
20
In the current month, MET has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 1,792.89.
Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $43.39 with a range of $40.57 to $44.82. The previous quarter’s EPS was $41.25. MET beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 81.82% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.
Next quarter’s earnings estimate for MET is $43.39 with a range of $40.57 to $44.82. The previous quarter’s EPS was $41.25. MET beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 81.82% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $341.17B with a range of $336.03B to $349.10B. The previous quarter’s sales results were $327.83B. MET beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 93.33% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.
Next quarter’s sales forecast for MET is $341.17B with a range of $336.03B to $349.10B. The previous quarter’s sales results were $327.83B. MET beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 93.33% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Stock Forecast FAQ

What is MX:MET’s average 12-month price target, according to analysts?
Based on analyst ratings, Metlife’s 12-month average price target is 1,792.89.
    What is MX:MET’s upside potential, based on the analysts’ average price target?
    Metlife has 7.86% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Metlife a Buy, Sell or Hold?
          Metlife has a consensus rating of Strong Buy, which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Metlife’s share price target?
            The average share price target for Metlife is 1,792.89. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $2,011.05 ,and the lowest forecast is $1,520.96. The average share price target represents 7.86% Increase from the current price of $1,662.26.
              What do analysts say about Metlife?
              Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Metlife?
                To buy shares of MX:MET, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.